Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system

被引:452
作者
Palmer, BF [1 ]
机构
[1] Univ Texas, SW Med Sch, Dept Med, Div Nephrol, Dallas, TX 75390 USA
关键词
D O I
10.1056/NEJMra035279
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:585 / 592
页数:8
相关论文
共 59 条
[1]   Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol - Clinical, endoscopic, and histopathologic findings [J].
Abraham, SC ;
Bhagavan, BS ;
Lee, LA ;
Rashid, A ;
Wu, TT .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (05) :637-644
[2]   Hyperkalemia in hospitalized patients -: Causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines [J].
Acker, CG ;
Johnson, JP ;
Palevsky, PM ;
Greenberg, A .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (08) :917-924
[3]   Predictors of the development of hyperkalemia in patients using angiotensin-converting enzyme inhibitors [J].
Ahuja, TS ;
Freeman, D ;
Mahnken, JD ;
Agraharkar, M ;
Siddiqui, M ;
Memon, A .
AMERICAN JOURNAL OF NEPHROLOGY, 2000, 20 (04) :268-272
[4]  
[Anonymous], 1995, MMWR Morb. Mortal. Wkly. Rep, V44, P853
[5]   HYPERKALEMIA AND RENAL-INSUFFICIENCY - ROLE OF SELECTIVE ALDOSTERONE DEFICIENCY AND TUBULAR UNRESPONSIVENESS TO ALDOSTERONE [J].
ARRUDA, JAL ;
BATLLE, DC ;
SEHY, JT ;
ROSEMAN, MK ;
BARONOWSKI, RL ;
KURTZMAN, NA .
AMERICAN JOURNAL OF NEPHROLOGY, 1981, 1 (3-4) :160-167
[6]   Complications of inappropriate use of spiroholactone in heart failure: When an old medicine spirals out of new guidelines [J].
Bozkurt, B ;
Agoston, I ;
Knowlton, AA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (02) :211-214
[7]  
Braunwald E, 2004, NEW ENGL J MED, V351, P2058
[8]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[9]   ATTENUATION OF ANGIOTENSIN-II-INDUCED AND ANGIOTENSIN-III-INDUCED ALDOSTERONE RELEASE BY PROSTAGLANDIN SYNTHESIS INHIBITORS [J].
CAMPBELL, WB ;
GOMEZSANCHEZ, CE ;
ADAMS, BV ;
SCHMITZ, JM ;
ITSKOVITZ, HD .
JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (06) :1552-1557
[10]   ADRENERGIC MODULATION OF POTASSIUM METABOLISM DURING EXERCISE IN NORMAL AND DIABETIC HUMANS [J].
CASTELLINO, P ;
SIMONSON, DC ;
DEFRONZO, RA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 252 (01) :E68-E76